四级杆飞行时间串联质谱高通量筛查鱼肉中的药物残留

建立了以QuEChERS样品预处理方法、四级杆飞行时间串联质谱(Q-TOF MS)为检测手段,针对鱼肉中的四环素类、磺胺类、喹诺酮类、三苯甲烷类、雄激素、孕激素和糖皮质激素7类59种残留药物的快速筛查技术。通过正交实验得到优化条件为:Na2EDTA-Mcllvaine为缓冲溶液,乙腈为提取剂,净化剂无水MgSO4、十八烷基键合硅胶(C18)和N-丙基乙二胺(PSA)的用量分别为每毫升提取液加入25,12.5和6.25 mg。对Q-TOF质谱筛查出的阳性样品,再用LC-MS/MS对样品进行确证。本方法对59种药物的检出下限为0.5~5.3μg/kg。本方法快速、简单、可靠,可筛查的渔药种类覆盖面广,灵敏度满足水产品药物残留检测的要求,适用于鱼类水产品中残留药物的快速测定。     

QuEChERS-同位素稀释-液相色谱-高分辨飞行时间质谱法高通量筛查化妆品中86种糖皮质激素

建立了QuEChERS-同位素稀释-液相色谱-四极杆串联飞行时间质谱同时快速筛查化妆品中86种糖皮质激素(Glucocorticoids, GCs)的高通量方法.样品经乙腈提取,改进的QuEChERS法净化,待测物选用具有多重色谱保留机理的新型色谱柱Poroshell 120 PFP (100 mm×2.1 mm,2.7 μm),以0.2% (V/V)乙酸和乙腈为流动相进行梯度洗脱分离,在电喷雾离子源的正离子模式下建立了一级精确质量数及二级碎片离子质谱图数据库,无需标准品即可完成化妆品中86种GCs的全面筛查与确证.所有待测物在2~200 μg/L浓度范围内线性良好,相关系数均大于0.99, 3个添加水平的平均回收率为66.2%~112.8%,相对标准偏差(RSD)为4.6%~13.9%,检出限(LOD,S/N≥3) 为0.006~0.015 mg/kg,定量限(LOQ,S/N≥10)为0.02~0.05 mg/kg.本方法简便高效、定性可靠、定量准确,适用于化妆品中非法添加GCs的高通量筛查.     

化学计量学-动力学分光光度法同时测定两种糖皮质类激素

在碱性介质中,高锰酸钾能将糖皮质类激素(醋酸泼尼松和地塞米松)氧化,而本身被还原成绿色的锰酸钾,基于这一反应,本文提出了同时测定醋酸泼尼松和地塞米松的化学计量学-动力学分光光度法.研究发现反应体系在610 nm处有一个吸收峰,实验以该波长为检测波长,优化实验条件.在该条件下,检测醋酸泼尼松和地塞米松的线性范围分别为0....     

分散固相萃取净化与液相色谱/串联质谱法测定牛奶中8类禁用药物残留

建立了牛奶中8类禁用药物的液相色谱-串联质谱( LC- MS/MS)检测方法.分析物包括5种硝基咪唑、7种β-受体激动剂、9种雄性激素、7种糖皮质激素、3种雌性激素、2种镇静剂、1种氯霉素以及6种二羟基苯甲酸内酯共40种禁用药物.样品以β葡萄糖苷醛酶/芳基硫酸酯酶在乙酸铵缓冲液中酶解,用氨化和酸化乙腈各提取一次.提取液经改良的分散固相萃取(QuEChERS)净化,浓缩后采用C18色谱柱分离(150 mm×2.1 mm i.d.,3.0 um).以甲醇和水(含0.1％甲酸)、乙腈和水分别作为正、负电喷雾离子化模式的色谱分离流动相进行梯度洗脱,多反应监测模式进行定性和定量分析.7种药物以内标法定量;33种药物以基质标准曲线外标法定量,氯霉素在0.02～0.4μg/kg; 39种药物在0.20～ 10.0 μg/kg范围内相关系数(r)均大于0.99;定量限(S/N=10)在0.07～0.93 μg/kg之间.分别以各个药物0.5,1和2倍MRPL( Minimum required performance limits)浓度水平加标验证实验,回收率范围60.3％～119.3％范围;相对标准偏差小于18.9％.     

Determination of endogenous and synthetic glucocorticoids in human urine by gas chromatography-mass spectrometry following microwave-assisted derivatization

A complete screening and confirmation analytical method for the direct determination of six endogenous (cortisol, cortisone, deoxycorticosterone, tetrahydrocortisol, tetrahydrocortisone, tetrahydro-S) and 17 synthetic (amcinonide, betamethasone, desoximethasone, dexamethasone, fludrocortisone, flumethasone, flunisolide, flucinolone acetonide, flucinonide, fluprednisolone, flurandrenolide, fluorometholone, 6-methylprednisolone, prednisolone, prednisone, triamcinolone, triamcinolone acetonide) glucocorticoids in human urine by gas chromatography with mass spectrometric detection (GC-MS) is presented.The analytical technique comprises a pre-treatment procedure and the instrumental analysis of the trimethylsilyl (TMS) derivatives, performed by GC-MS (quadrupole) with electron impact (EI) ionization. The derivatization yields obtained by two different derivatizing mixtures, namely N-methyl-N(trimethylsilyl)trifluoroacetamide (MTSFA):NH₄I:dithioerythritol (DTE) 1000:2:4 (usually indicated as TMSiodine); and N-trimethylsilylimidazole (TMSim):N,O-bis(trimethylsilyl)acetamide (BSA):trimethylchlorosilane (TMCS) 3:3:2, both under direct thermal heating and with microwave (MW) irradiation, were evaluated, also as a function of the temperature, of the MW power and of the incubation time.The highest yields of the derivatization process were obtained, for most of the compounds here considered, by a two-step procedure: a microwave-assisted derivatization stage (40 min in a microwave oven at 900 W emitted power), followed by a traditional heat transfer derivatization (1.5 h in a thermostated bath at 70 °C) with the derivatization mixture TMSim:BSA:TMCS 3:3:2. In these operating conditions, diagnostic EI-MS spectra of all considered glucocorticoids were obtained. Limits of detection (LOD) of synthetic glucocorticoids in urine ranged from 3 to 25 μg/l. The effectiveness of the method for the determination of glucocorticoids in urine was evaluated on spiked urine samples and on real samples obtained from patients under pharmacological treatment with synthetic glucocorticoids.Apart from the clinical monitoring of glucocorticoids in urine, the method can be applied as a complete screening + confirmation analytical protocol in antidoping tests for the detection of illicit administration of glucocorticoids by the athletes.     

Effect of the systemic versus inhalatory administration of synthetic glucocorticoids on the urinary steroid profile as studied by gas chromatography-mass spectrometry

This paper presents a gas chromatography-mass spectrometry (GC-MS) study carried out on human urine to verify whether the administration of glucocorticoids can affect the urinary steroid profile, and especially the levels of endogenous glucocorticoids, androgens and their main metabolites.Betamethasone and beclomethasone, administered either systemically (per os or i.m.) or locally (by inhalation) have been studied. The determination of the urinary levels of endogenous glucocorticoids and androgens was carried out by GC-MS in electron impact ionization mode. Data were evaluated taking into account the baseline individual variability, and compared with values obtained on a control group.Detectable differences were recorded in the steroids metabolites excretion profiles between men and women. The circadian variability of the steroid profile was the same for both sexes, showing a maximum during the morning hours. After systemic treatment with synthetic glucocorticoids, the relative urinary concentrations of corticosteroids, androgens and of their metabolites were significantly altered, recording a transient decrease of the concentration of cortisol and tetrahydrocortisol and a parallel, although less pronounced, increase of the concentration of testosterone, epitestosterone and related androgenic steroids; while no effects were recorded if the administration was by inhalation.     

Histomorphometric analysis of glucocorticoid-induced osteoporosis

Bone histomorphometry or quantitative histology consists of counting or measuring tissue components: cells, extracellular constituents and microarchitecture. Bone histomorphometry is the only method that allows the measurement of mineralization rate and the study of bone formation at three levels: cell, remodeling unit and tissue levels. It is a useful tool to explain the pathogenesis and cellular mechanisms of different metabolic bone diseases such as glucocorticoid-induced osteoporosis (GIO).

Glucocorticoids (GC) affect calcium and bone metabolism at every level, but the main effect is the osteoblastic dysfunction.

Concerning the bone formation, some histomorphometric studies have shown a depressed osteoblastic activity at a cell, bone remodeling unit, and tissue levels. In addition, there is evidence of a shortening of the period in which the osteoblasts work actively forming the bone matrix. This latter effect seems to occur after high cumulative doses of GC. With regard to the resorption, the results are still debated, but histomorphometric parameters seem to be increased in the majority of studies, at least in the first period of the GC treatment. From a structural point of view, GC seem to induce a thinning of the trabeculae without their perforation, which occurs only after high cumulative doses. Antiresorptive treatments, such as bisphosphonates, are able to counteract the negative effects of GC on bone. In particular, along with their active working period, they prolong the lifespan of osteoblasts and osteocytes. In addition, the antiresorptive treatments seem to extend the time for secondary mineralization through a reduction of the Activation Frequency. The latter is an intriguing mechanism of bisphosphonates in GIO that needs further ad hoc investigations.     

Separation and pre‐concentration of glucocorticoids in water samples by ionic liquid supported vortex‐assisted synergic microextraction and HPLC determination

We have developed a synergic microextraction procedure based on ionic liquid for the pre‐concentration and determination of glucocorticoids in water samples. Using nonionic surfactant Triton X‐100 (TX‐100) as synergic reagent, 1‐butyl‐3‐methylimidazolium hexa‐fluorophosphate accomplished extraction rapidly without heating in water bath. One key property of ionic liquids that highlights their potential is their wide liquid temperature range. The improved extraction was named as ionic liquid supported vortex‐assisted synergic microextraction. Compared with the traditional liquid–liquid extraction and cloud point extraction, ionic liquid supported vortex‐assisted synergic microextraction was accomplished in 8 min with considerably high recovery. The proposed method greatly improved the sensitivity of HPLC for the determination of glucocorticoids. The results obtained indicated a good linearity with the correlation coefficient of 0.997 over the range of 0.6–300 ng/mL and high sensitivity with LODs of 4.11, 9.19, and 7.50 ng/mL for hydrocortisone butyrate, beclomethasone dipropionate, and nandrolone phenylpropionate, respectively. The RSD of the method was 1.57–1.81% (n = 6) with enrichment factor of 99.85, and good recovery (≥97.24%). The method was successfully applied to the determination of glucocorticoids in mineral water, water of Dianchi lake, and tap water samples.     

高效液相-电喷雾串联质谱法测定动物肌肉组织中的糖皮质激素

本实验建立了肌肉组织中氢化可的松、可的松、泼尼松和地塞米松含量的高效液相色谱-电喷雾串联质谱(LC-ESI-MS/MS)检测方法.样品经酶水解、乙酸乙酯提取、HLB固相萃取净化,C8色谱柱分离,在多反应选择性监测模式(MRM)下采用负离子模式进行信号采集和测定.4种糖皮质激素的检出限为0.13 ～0.25 μg/kg,定量限为0.25 ～ 0.5 μg/kg.在0.5～50.0 μg/L范围内具有良好的线性关系(R2＞0.99).在0.5,5.0和10.0μg/kg基质加标水平下,4种物质的平均回收率为74.0％ ～ 101.8％,相对标准偏差0.7％ ～8.6％.     

Preparative HPLC for analysis of mineralocorticoids in human plasma

Summary A method has been developed to measure simultaneously in human plasma the mineralocorticoids and glucocorticoids involved in mineralocorticoid excess. Briefly: plasma extracts were chromatographied in a fully-automated procedure on a lichrospher-diol column using a hexane: isoproanol: trithylamine gradient. Eluates were collected on a preprogrammed fraction collector. Final quantification was achieved by RIA on the selected fractions. This procedure allowed: 1) the separation of each measured steroid from plasma contaminants; 2) precise collection; 3) quantification of mineralocorticoids with a precision and sensitivity equivalent to that of direct methods; and 4) improved specificity.